NantHealth Inc (NH) Lifted to “Hold” at BidaskClub
NantHealth Inc (NYSE:NH) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Friday.
Several other equities research analysts have also recently issued reports on NH. Jefferies Group LLC reissued a “buy” rating and issued a $5.50 price objective (down from $8.00) on shares of NantHealth in a research report on Monday, June 19th. Canaccord Genuity reissued a “buy” rating and issued a $6.00 price objective (down from $8.00) on shares of NantHealth in a research report on Monday, August 21st. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $8.55.
NantHealth (NH) traded down 1.07% during trading on Friday, reaching $4.63. 1,210,847 shares of the company were exchanged. The company’s 50-day moving average price is $4.46 and its 200-day moving average price is $5.81. The stock’s market capitalization is $564.61 million. NantHealth has a 1-year low of $4.00 and a 1-year high of $14.62.
NantHealth (NYSE:NH) last released its quarterly earnings results on Thursday, August 10th. The company reported ($0.58) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.32). The firm had revenue of $26.23 million for the quarter, compared to analysts’ expectations of $31.28 million. NantHealth had a negative return on equity of 83.97% and a negative net margin of 267.11%. NantHealth’s revenue for the quarter was down 16.7% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.15) earnings per share. On average, equities analysts forecast that NantHealth will post ($0.70) EPS for the current year.
A number of institutional investors have recently added to or reduced their stakes in the business. California State Teachers Retirement System boosted its position in NantHealth by 132.4% in the 2nd quarter. California State Teachers Retirement System now owns 31,600 shares of the company’s stock valued at $134,000 after buying an additional 18,000 shares during the period. State Street Corp boosted its position in NantHealth by 88.1% in the 2nd quarter. State Street Corp now owns 147,234 shares of the company’s stock valued at $623,000 after buying an additional 68,963 shares during the period. Goldman Sachs Group Inc. boosted its position in NantHealth by 91.5% in the 2nd quarter. Goldman Sachs Group Inc. now owns 169,603 shares of the company’s stock valued at $717,000 after buying an additional 81,024 shares during the period. Vanguard Group Inc. boosted its position in NantHealth by 20.2% in the 2nd quarter. Vanguard Group Inc. now owns 423,537 shares of the company’s stock valued at $1,792,000 after buying an additional 71,087 shares during the period. Finally, Northern Trust Corp boosted its position in NantHealth by 133.9% in the 2nd quarter. Northern Trust Corp now owns 151,907 shares of the company’s stock valued at $643,000 after buying an additional 86,955 shares during the period.
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.